Miami, FL, [November 1, 2018] — Neocis, Inc., an innovator in dental implant surgery utilizing advanced robotics, announced today that Fred Moll, M.D. has joined its board of directors as of September 2018.

“Fred is a respected industry leader and an ideal fit for our board,” said Alon Mozes, PhD, Chief Executive Officer. “His impressive career has been dedicated to revolutionizing medicine. In the field of surgical robotics, he has demonstrated repeated success both developing and commercializing novel technologies that have had a meaningful impact on patient care. He has been an investor and advisor since the start of the company, and his direction will be vital as we advance our FDA-cleared Yomi robotic assistant for dental implant surgery.”

Dr. Moll’s extensive career has included leadership roles in multiple innovative medical device companies. Most recently, Dr. Moll founded Auris Health, Inc. where he currently serves as Chief Executive Officer. Prior to Auris, Dr. Moll co-founded Hansen Medical and served as the company’s Chief Executive Officer. Previously, he co-founded Intuitive Surgical, Inc. and served as its first Chief Executive Officer. Dr. Moll also co-founded Origin Medsystems, Inc., which became an operating company within Guidant Corporation, following its acquisition by Eli Lilly. He also served as Medical Director of Guidant’s Surgical Device Division. Before co-founding Origin Medsystems, Dr. Moll invented the safety trocar, which fostered in modern general laparoscopic surgery, and he founded Endotherapeutics, which was acquired by U.S. Surgical.

Dr. Moll holds a B.A. degree in economics from the University of California at Berkeley, a M.S. degree in management from Stanford University, and a M.D. from the University of Washington. He is a distinguished speaker and lecturer and is the author of numerous scientific articles. He currently serves on the boards of several healthcare companies including Cephea Valve, ShockWave Medical, RefleXion, MIVI Neuroscience, and Restoration Robotics.

“I’m delighted to join the board of a company that is dedicated to innovation and committed to bringing new approaches to improve patient care,” Dr. Moll said. “With the Yomi robot, a surgeon now has the capability to perform a procedure exactly as planned, offering the potential to dramatically change how dental surgery is performed today.”

About Neocis, Inc.
Neocis® is a private company located in Miami, Florida that is transforming dental implant surgery with advanced robotics, with a vision of advancing healthcare through the latest technology. The company’s FDA cleared Yomi® provides a computerized navigational system that assists in both the planning and the surgical phases of dental implant surgery. Yomi provides surgical guidance through the use of haptic robotic technology, software, and multisensory feedback to help achieve the right position, angulation, and depth to place the implant exactly according to plan. Yomi enables a minimally invasive flapless approach, which has been proven to lead to faster surgery, faster recovery, and less pain for the patient. Learn more at www.neocis.com

Contact
Leigh Salvo or Carrie Mendivil
(415) 937-5404
leigh@gilmartinir.com